Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve to consider and approve unaudited financial results for the quarter ended 30th september 2026

BERYIL orves Lmreo Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INDORE-452016 (M.P.) INDIA Tel. : (0731) 2517677 | E-mail : beryldrugs25@yahoo.com | CIN : L02423MP1993PLC007840 Date: 6" November, 2026 The Secretary, The Bombay Stock Exchange Limited, Ground Floor, P. J. Tower, Dalal Street, Fort, Mumbai - 400001 BSE Code: 524606 NOTICE FOR 6/2026-2027 BOARD MEETING Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that 06/2026-2027 Meeting of Board of Directors of the Company is scheduled to be held on Saturday, 14™ November, 2026 at 02:00 P.M. at the Registered Office of the company situated at 29, Neer Nagar, Mayank Water Park Road, Bicholi, Indore (M.P.) 452016, inter alia consider and approve the following matters along with other routine businesses: 1. To consider and approve Unaudited Financial Results for the quarter ended 30th September, 2026 of the company. 2. To adopt and approve Limited Review Report for the quarter ended 30th September, 2026 of the company. 3. Any other matter with the permission of chair. Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in securities of the Company which was closed from 01 July 2026 will open after 48 hours from the conclusion of Board Meeting to be held on 14™" November, 2026 You are requested to kindly take the same on record for your further needful For Beryl Drugs Limited Sudhir Sethi Chairman& Dire DIN: 00090172